Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0220
0.00 (0.00%)
Jul 10, 2026, 3:22 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 84.27 million as of July 10, 2026. Its market cap has increased by 563.86% in one year.
Market Cap
84.27M
Enterprise Value
79.62M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 84.27M, an increase of 114.12%. That is a compound annual growth rate of 2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 84.27M | 154.89% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 112.30M |
| LTR Pharma | 103.61M |
| Nyrada | 100.43M |
| Paradigm Biopharmaceuticals | 89.33M |
| Arovella Therapeutics | 79.78M |
| Prescient Therapeutics | 76.76M |
| Immutep | 76.63M |
| Radiopharm Theranostics | 70.88M |